Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute.
-
Researchers have surveyed the genetic changes in nearly 300 head and neck cancers, revealing some previously unknown alterations that may play a role in the disease, including in patients whose cancer is associated with the human papillomavirus (HPV).
-
Under the Precision Medicine Initiative, NCI is working to accelerate the pace of research that will help identify which treatments work best for which patients.
-
In 2014, the Food and Drug Administration (FDA) approved 41 drugs that had not been approved previously for any indication, the most in nearly 20 years. Of these 41 novel drugs, 9 were approved for the treatment of cancer or cancer-related conditions.
-
A new study suggests that dense bacterial communities called biofilms may promote the development of some colorectal cancers.
-
New research suggests that identifying specific changes in the gut microbiome could potentially help screen patients for colorectal cancer.
-
The first report of its kind finds that more than 300 million people worldwide use smokeless tobacco products and that they are linked to a number of cancers.
-
Several new resources that provide more details about the changing treatment landscape for advanced melanoma have recently been added to Cancer.gov.
-
Researchers have identified a “genetic signature” in the tumors of patients with advanced melanoma who responded to a form of immunotherapy called checkpoint blockade. The results could be the basis for a test that identifies likely responders to this treatment as well as for developing new treatments.
-
Researchers from the Massachusetts General Hospital Cancer Center in Boston have reported on a method for studying treatment resistance that may identify combinations of targeted therapies that can help to combat resistance in some patients.
-
Since they first began to be sold in North America in the mid-2000s, electronic cigarettes have been the subject of intense debate. NCI's Dr. Michele Bloch recently presented an update on some of the issues surrounding e-cigarettes.